John H Tucker - Net Worth and Insider Trading
John H Tucker Net Worth
The estimated net worth of John H Tucker is at least $229,879 dollars as of 2024-05-08. John H Tucker is the President and CEO of scPharmaceuticals Inc and owns about 46,962 shares of scPharmaceuticals Inc (SCPH) stock worth over $229,879. Details can be seen in John H Tucker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John H Tucker has not made any transactions after 2021-12-03 and currently still holds the listed stock(s).
Transaction Summary of John H Tucker
John H Tucker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John H Tucker owns 1 companies in total, including scPharmaceuticals Inc (SCPH) .
Click here to see the complete history of John H Tucker’s form 4 insider trades.
Insider Ownership Summary of John H Tucker
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SCPH | scPharmaceuticals Inc | 2021-12-03 | director & President and CEO |
John H Tucker Latest Holdings Summary
John H Tucker currently owns a total of 1 stock. John H Tucker owns 46,962 shares of scPharmaceuticals Inc (SCPH) as of December 3, 2021, with a value of $229,879.
Latest Holdings of John H Tucker
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SCPH | scPharmaceuticals Inc | 2021-12-03 | 46,962 | 4.90 | 229,879 |
Holding Weightings of John H Tucker
John H Tucker Form 4 Trading Tracker
According to the SEC Form 4 filings, John H Tucker has made a total of 2 transactions in scPharmaceuticals Inc (SCPH) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in scPharmaceuticals Inc is the acquisition of 10,000 shares on December 3, 2021, which cost John H Tucker around $39,600.
Insider Trading History of John H Tucker
- 1
John H Tucker Trading Performance
GuruFocus tracks the stock performance after each of John H Tucker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John H Tucker is 34.34%. GuruFocus also compares John H Tucker's trading performance to market benchmark return within the same time period. The performance of stocks bought by John H Tucker within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John H Tucker's insider trading performs compared to the benchmark.
Performance of John H Tucker
John H Tucker Ownership Network
Ownership Network List of John H Tucker
Ownership Network Relation of John H Tucker
John H Tucker Owned Company Details
What does scPharmaceuticals Inc do?
Who are the key executives at scPharmaceuticals Inc?
John H Tucker is the director & President and CEO of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and 10 percent owner Ra Capital Healthcare Fund Lp .
scPharmaceuticals Inc (SCPH) Insider Trades Summary
Over the past 18 months, John H Tucker made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 762,380 shares made by Orbimed Advisors Llc ,
In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 762,380 shares were bought by its insiders, resulting in a net purchase of 762,380 shares.
scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
scPharmaceuticals Inc Insider Transactions
John H Tucker Mailing Address
Above is the net worth, insider trading, and ownership report for John H Tucker. You might contact John H Tucker via mailing address: Indevus Pharmaceuticals, Inc., 99 Hayden Avenue, Lexington Ma 02421.